Countries
Institutions
Fields
Rankings
Compare

Search institutions, scholars, countries and publications

Sankore

Named after the University of Sankore in Timbuktu — one of the world’s oldest centres of learning. Every figure here is computed from work-level records in our own graph, never copied from a source’s summary count.

Built from

OpenAlex — works, authorships, subject classification
ROR — institutional identity
ORCID — researcher identity
Crossref — publisher confirmation

Browse

Countries
Institutions
Fields
Rankings
What we cover

Coverage is partial and says so. A country appears with its research output only once its works have been swept; until then the portal shows whatever the graph happens to hold for it and labels it as exactly that.

Innovative biotherapeutics for antimicrobial resistance: From monoclonal antibodies to phage therapy

2026American Journal of Biopharmacy and Pharmaceutical SciencesJournalOpen access

10.25259/ajbps_18_2025 Full text0 citations

Authors

7 authors across 4 institutions in 3 countries.

Courage ChandipwisaFirst authorCorresponding
- National HIV/AIDS/STI/TB Council (ZM)
Courage ChandipwisaFirst authorCorresponding
- National HIV/AIDS/STI/TB Council (ZM)
Agness Shimilimo
- Cocoa Research Institute of Nigeria (NG)
Agness Shimilimo
Akanbi-Hakeem Hauwa Bolanle
- Nile University of Nigeria (NG)
Warsame Hashi Omar
- Benadir University (SO)
Harrison BandaSenior author
- University of Zambia (ZM)

Fields

Assignment is probabilistic — a work belongs to several fields in proportions.

Bacteriophages and microbial interactionslevel 3 · 0.77
Cancer Research and Treatmentslevel 3 · 0.04
Monoclonal and Polyclonal Antibodies Researchlevel 3 · 0.02

Sources

Several sources describing one work is the point — it means the record rests on more than one authority.

openalexseen September 24, 2026
2026 · American Journal of Biopharmacy and Pharmaceutical Sciences · 0 citations
https://openalex.org/W7131362240

Innovative biotherapeutics for antimicrobial resistance: From monoclonal antibodies to phage therapy · Sankore